Global Allergy Treatment Market Report 2021: The market is


[ad_1]

Dublin, April 29, 2021 (GLOBE NEWSWIRE) – The “Forecast of the allergy treatment market until 2028 – COVID-19 impact and global analysis by type of allergy (eye allergy, rhinitis, asthma, skin allergy, food allergies and other allergies); treatment (antiallergic drugs and immunotherapy) and geography “ the report was added to ResearchAndMarkets.com offer.

The global allergy treatment market is expected to reach US $ 35,812.33 million by 2028, compared to US $ 21,160.92 million in 2020; it is estimated to increase at a CAGR of 6.9% from 2020 to 2028.

Growing adoption of immunotherapy in allergy treatment and developments in food allergy treatment are the factors driving the growth of the global allergy treatment market. However, the lack of awareness of allergies and their treatments is holding back the growth of the market.

Allergies are hypersensitive responses of the human immune system to a substance foreign to the body. Dust mites, animal dander, cockroaches, pollens, molds, food substances and particles of metals and elements are some of the common allergens. While allergies can disrupt normal organ function, severe allergies can be life threatening; for example, asthma causes poor lung function. Although the most effective method of achieving allergy protection is to avoid exposure to known allergens, drugs such as steroids and antihistamines are available to treat them.

Immunotherapy comes in two different types – allergy shots and sublingual immunotherapy (STIL). Allergy shots are extracts of allergens administered in increasing doses; they are effective against allergies caused by asthma, pets, dust, pollen, bees and other stinging insects. Usually, SLIT tablets are administered daily by keeping them under the tongue; this type is an effective treatment option for nasal allergies and asthma.

The administration of repeated doses of the allergen makes the patients less sensitive to this allergen, thus providing relief of the allergic symptoms. Immunotherapy has shown positive and long-term benefits in allergic patients. In addition, it is suitable for self-administration and drug use in home care settings. As a result, immunotherapy has become a safe and effective alternative subcutaneous route for chronic and recurrent allergies.

Various studies have shown that immunotherapy reduces allergic symptoms by 60-65% in patients who have completed their allergen doses. According to a study published in Annals of Allergy, Asthma and Immunology Journal in February 2016, approximately 70% of allergic patients do not need medication for their allergic reactions. The study also indicated that immunotherapy is effective in children as well as the elderly population. Thus, the increasing adoption of immunotherapy in allergy treatment is fueling the growth of the allergy treatment market.

Information on types of allergies

Based on rhinitis, the global allergy treatment market is segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share of the market, and it is expected to continue to be the largest shareholder in the market by 2028.

With the dramatically increasing prevalence of rhinitis, possibly due to frequent climatic and environmental changes, the demand for treatment groups such as decongestants, antihistamines, and topical / oral steroids is also increasing worldwide.

Treatment information

Based on treatment, the global allergy treatment market is segmented into anti-allergic drugs and immunotherapy. The antiallergic drugs segment held a larger market share in 2020 and is expected to still dominate the market by 2028. These drugs are available in forms such as tablets, nasal sprays, inhalers, liquids, ointments, injections and eye drops.

Main topics covered:

1. Introduction
1.1 Scope of the study
1.2 Reporting guidelines
1.3 Market segmentation

2. Allergy Treatment Market – Key Points to Remember

3. Research methodology

4. Global Allergy Treatment Market – Market Landscape
4.1 Overview
4.2 PEST analysis
4.3 Expert advice
4.4 List of companies, by region

5. Allergy Treatment Market – Key Industry Dynamics
5.1 Main market drivers
5.1.1 Growing adoption of immunotherapy in the treatment of allergies
5.1.2 Developments in the treatment of food allergies
5.2 Main market constraints
5.2.1 Lack of awareness of allergy treatments
5.3 Key Market Opportunities
5.3.1 Growing number of allergy-related research projects and programs
5.4 Future trends
5.4.1 Development and approvals of innovative drugs such as biologics for the treatment of allergies and asthma
5.5 Impact analysis

6. Allergy Treatment Market – Global Analysis
6.1 Global Allergy Treatment Markers Revenue Forecast and Analysis
6.2 Global Allergy Treatment Market, By Geography – Forecast and Analysis
6.3 Market positioning of key players

7. Allergy Treatment Market Analysis – By Allergy Type
7.1 Eye allergy
7.2 Rhinitis
7.3 Asthma
7.4 Skin allergy
7.5 Food allergies
7.6 Other allergies

8. Allergy Treatment Market Analysis – By Treatment
8.1 Overview
8.2 Allergy Treatment Market, by Treatment 2020 and 2028 (%)
8.3 Anti-allergic drugs
8.3.1 Overview
8.3.2 Anti-Allergic Drugs: Allergy Treatment Market – Revenue and Forecast to 2028 (USD Million)
8.3.3 Antihistamines
8.3.4 Corticosteroids
8.3.5 Decongestants
8.4 Immunotherapy
8.4.1 Overview
8.4.2 Immunotherapy: Allergy Treatment Market Revenue and Forecast to 2028 (Million USD)
8.4.3 Subcutaneous Immunotherapy (SCIT)
8.4.4 Sublingual Immunotherapy (STIL)

9. Allergy Treatment Market – Geographic Analysis

10. Impact of the COVID-19 pandemic on the global allergy treatment market

11. Allergy Treatment Market – Industry Landscape
11.1 Overview
11.2 Growth strategies implemented by market companies, (%)
11.3 Organic developments
11.4 Inorganic developments

12. Company profiles

  • Johnson and Johnson Services, Inc.
  • Sanofi
  • AbbVie Inc. (Allergan plc)
  • Pfizer Inc.
  • LETIPharma
  • ALK-Abello A / S
  • Allergy therapy
  • Stallergenes Greer
  • GlaxoSmithKline plc
  • Dermapharm Holding

For more information on this report, visit https://www.researchandmarkets.com/r/awa8vf


[ad_2]

Comments are closed.